該雜志國際簡稱:HERED CANCER CLIN PR,是由出版商BioMed Central出版的一本致力于發(fā)布醫(yī)學研究新成果的的專業(yè)學術(shù)期刊。該雜志以O(shè)NCOLOGY研究為重點,主要發(fā)表刊登有創(chuàng)見的學術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術(shù)發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術(shù)影響力。
《Hereditary Cancer In Clinical Practice》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱臨床實踐中的遺傳性癌癥,本刊主要出版、報道醫(yī)學-ONCOLOGY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為2,最新CiteScore 指數(shù)為3.1。
英文介紹
Hereditary Cancer In Clinical Practice雜志英文介紹
Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies.
Cancer genetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care.
Topics covered by the journal include but are not limited to:
Original research articles on any aspect of inherited predispositions to cancer.
Reviews of inherited cancer predispositions.
Application of molecular and cytogenetic analysis to clinical decision making.
Clinical aspects of the management of hereditary cancers.
Genetic counselling issues associated with cancer genetics.
The role of registries in improving health care of patients with an inherited predisposition to cancer.
中科院SCI分區(qū)
Hereditary Cancer In Clinical Practice雜志中科院分區(qū)信息